An Evolving Regulatory Landscape Over the past few years, regulatory changes in the United States…

Biosafety Level 2 at ITRIn recent years, cell and gene therapies have been gaining grounds…

  Whether you’re exploring new drug candidates or refining a promising one, predictive AI models…

  Whether you are looking for more broad screening or you are narrowing down on…

  Assessing the biodistribution of gene therapies requires a highly sensitive approach, as even small…